Anti-inflammatory Drugs 3 Flashcards
Rheumatoid Arthritis (RA)
Buzzword: Extra-articular involvement
Joints, eyes, heart, lungs
F>M, all over the place, not localized Symmetrical arthritis Synovium first Bones get thinner Rhematoid factor is + (though not primary diagnostic test)
RA: Dx
Buzzword: rheumatoid nodules
1 - Early morning stiffness for 1 hour or longer
2 - Simultaneous swelling of 3 or more joints
Always order joint X-ray
Order ESR to look for inflammation, with RA = Elevated ESR
Wrist, PIP, NOT DIP
Elbow, ankle, knee
RA: Rx
First: NSAIDs or COX2 Inhibitors
If this doesn’t work within 3 months , go to Disease-Modifying Antirheumatic Drugs (DMARDS)
RA: DMARDs definition
Disease-Modifying Antirheumatic Drugs
Used when NSAIDs or COX2 inhibitors don’t work
RA: DMARDS - Methotrexate
MOA: Inhibits Dihydrofolate Reductase; cytotoxic to lymphocytes
Adverse effects: Bone marrow suppression, hair loss, mucositis, worsens nodules
*also a cancer drug for chemotherapy
RA: DMARDS - Hydroxychloroquine
MOA: Stabilizes lysosomes and decreases chemotaxis
Adverse effects: GI distress and visual dysfunction (Cinchonism), and hemolysis from G6PD deficiency)
Also, increased LFTs: increased AST and ALT elevations.
RA: DMARDS - Sulfasalazine
MOA: ASA inhibits COX2
Sulfapyridine: decrease B cell functions
Adverse: ASA (GI distress), Sulfapyridine: rash, hemolysis, SLE like syndrome
RA: DMARDS - Corticosteroids
For flaring
MOA: Decreases LTs, IL-2, and PAF (platelet activating factor)
Adverse effects: ACTH depression, susceptibility to infections
RA: DMARDS - Gold Salts
MOA: Decrease lysosomal and macrophages functions
Adverse effects: stomatitis, rash, bone marrow depression, proteinuria, and nephrotic syndrome
RA: DMARDS - D-Penicillamine
Suppress T-cell and decreased rheumatoid factor
Adverse effects: aplastic anemia, myasthenia gravis
RA: DMARDS - Cyclophosphamide
Alkylating agents used in severe cases
Adverse: hemorrhagic cystitis
RA: DMARDS - Azathioprine
Immunosuppressive in autoimmune disease
MOA: Inhibits purine synthesis
Side effects: bone marrow suppression
RA: New DMARDs (Biologics) - Infliximab
Monoclonal antibody
MOA: Decreases TNF
Adverse effects: Infusion reactions, infections
RA: New DMARDs (Biologics) - Etanercept (Enbrel)
A recombinant of TNF receptor
BINDS to TNF (not inhibit; binding decreases effects)
Adverse effect: Hypersensitivity, infections
RA: New DMARDs (Biologics) - Leflunomide
MOA: Inhibits pyrimidine synthesis, inhibits dihydro-acid dehydrogenase
Adverse effects: apopecia, rash, hepatotoxicity
RA: New DMARDs (Biologics) - Anakinra
MOA: IL-1 receptor antagonist
Adverse effects: Reaction at injection site, infection
RA: New DMARDs (Biologics) - Adalimumab (Humira)
Recombinant Monoclonal antibody
BINDS TO TNF
RA: New DMARDs (Biologics) - Abatacept
Co-stimulation modulator
MOA: Inhibits T-cell activation by binding to cell surface markers (proteins) on leukocytes
Rx of RA